Califia is developing novel drugs active against drug resistant cancers unresponsive to current therapies, while displaying minimal toxicity in humans.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free